Literature DB >> 29080631

Ophthalmic manifestations in neurofibromatosis type 1.

Michael Kinori1, Nickisa Hodgson2, Janice Lasky Zeid3.   

Abstract

Neurofibromatosis type 1 (NF1) is a relatively common multisystemic inherited disease and has been extensively studied by multiple disciplines. Although genetic testing and confirmation are available, NF1 remains a clinical diagnosis. Many manifestations of NF1 involve the eye and orbit, and the ophthalmologist, therefore, plays a significant role in the diagnosis and treatment of NF1 patients. Improvements in diagnostic and imaging instruments have provided new insight to study the ophthalmic manifestations of the disease. We provide a comprehensive and up-to-date overview of the ocular and orbital manifestations of NF1.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lisch nodules; neurofibromatosis type 1; optic pathway gliomas; plexiform neurofibromas; von Recklinghausen's disease

Mesh:

Substances:

Year:  2017        PMID: 29080631     DOI: 10.1016/j.survophthal.2017.10.007

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  16 in total

1.  Trametinib for orbital plexiform neurofibromas in young children with neurofibromatosis type 1.

Authors:  Helen Toledano; Gad Dotan; Rivka Friedland; Rony Cohen; Iftach Yassur; Hagit Toledano-Alhadef; Shlomi Constantini; Mika Shapira Rootman
Journal:  Childs Nerv Syst       Date:  2021-03-22       Impact factor: 1.475

2.  Neuroretinal dysfunction in patients affected by neurofibromatosis type 1.

Authors:  Antonietta Moramarco; Luca Lucchino; Fabiana Mallone; Michela Marcelli; Ludovico Alisi; Vincenzo Roberti; Sandra Giustini; Alessandro Lambiase; Marcella Nebbioso
Journal:  Int J Ophthalmol       Date:  2022-05-18       Impact factor: 1.645

3.  The Prevalence of Ocular Manifestations in the Various Types of Common Skin Disorders at Tertiary Hospital in Ahmedabad, India.

Authors:  Vijaykumar M Damor; Anupama J Gosai; Shabnam G Ipli
Journal:  Cureus       Date:  2022-06-12

4.  Neurofibromatosis Type 1: Ocular Electrophysiological and Perimetric Anomalies.

Authors:  Marcella Nebbioso; Antonietta Moramarco; Alessandro Lambiase; Sandra Giustini; Marco Marenco; Emanuele Miraglia; Pasquale Fino; Chiara Iacovino; Ludovico Alisi
Journal:  Eye Brain       Date:  2020-10-21

5.  Tuberous sclerosis complex: a clinical case with multiple ophthalmological manifestations.

Authors:  Tiago Maio; José Lemos; Jorge Moreira; Filipa Sampaio
Journal:  BMJ Case Rep       Date:  2018-10-25

6.  Magnetic resonance imaging (MRI) features of cataracts in pediatric and young adult patients.

Authors:  Elie Barakat; Daniel Thomas Ginat
Journal:  Quant Imaging Med Surg       Date:  2020-02

7.  Ocular biometric parameters changes and choroidal vascular abnormalities in patients with neurofibromatosis type 1 evaluated by OCT-A.

Authors:  Aldo Vagge; Paolo Corazza; Lorenzo Ferro Desideri; Paola Camicione; Giulia Agosto; Roberta Vagge; Calevo Maria Grazia; Adriano Carnevali; Giuseppe Giannaccare; Massimo Nicolò; Carlo Enrico Traverso
Journal:  PLoS One       Date:  2021-05-06       Impact factor: 3.240

8.  Retinal vasoproliferative tumour-induced intractable neovascular glaucoma in a child with neurofibromatosis type 1.

Authors:  Deepika C Parameswarappa; Abhilasha Arvind Alone; Padmaja Kumari Rani
Journal:  BMJ Case Rep       Date:  2020-08-26

9.  Neovascular glaucoma in a pediatric patient with neurofibromatosis type 1: a case report.

Authors:  Sha Liu; Li Ran; Dongmei Qi; Xiaohong Meng; Tao Yu
Journal:  BMC Ophthalmol       Date:  2020-04-28       Impact factor: 2.209

10.  Hyperpigmented spots at fundus examination: a new ocular sign in Neurofibromatosis Type I.

Authors:  Antonietta Moramarco; Fabiana Mallone; Marta Sacchetti; Luca Lucchino; Emanuele Miraglia; Vincenzo Roberti; Alessandro Lambiase; Sandra Giustini
Journal:  Orphanet J Rare Dis       Date:  2021-03-23       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.